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In vivocarcinogenicitytesting is anexpensive andtime-consuming process, and as aresult, onlya
relativelysmall fraction ofnew and existing chemicals has been tested inthis manner. Therefore,
the development andvalidation ofalternative approaches is desirable. We previously developed a
mammalian in vitroassayforgenotoxicitybased onthe abilityofcells to increase theirlevel ofthe
tumor-suppressor protein p53 in response to DNA damage. Cultured cells are treatedwith van-
ous amounts ofthe test substances, and at defined times following treatment, they are harvested
and lysed. The lysates are analyzed for p53 byWestem blot and/or enzyme-linked immunosor-
bent assay analysis. An increase in cellular p53 following treatment is interpreted as evidence for
DNA damage. To determine the ability ofthis p53-induction assay to predict carcinogiy in
rodents and to compare such results with those obtained USing alternate approaches, we subjected
25 chemicals from the predictive toxicology evaluation 2 list to analysis with this method. Five
substances (citral, cobalt sulhate heptahydrate, D&C Yellow No. 11, oymetholone, and t-butyl-
hydroquinone) tested positive in this assay, and three substances (emodin, phenolphthalein, and
sodium ylenesulfonate) tested as possibly positive. Comparisons between the results obtained
withthis assayand those obtainedwith the in vivoprotocol, the Salmonellaassay, andthe Syrian
hamsterembryo (SHE) cell assayindicate thatthep53-induction assayis an excellent predictor of
the limited number ofgenotoxic carcinogens in this set, and that its accuracy is roughlyequiva-
lentto or better than the SalmonceUaand SHEassaysforthe completesetofchemicals. Keyworkr.
assay development, carcinogenicity, genotoxicity, p53, PTE2. Environ Health Perspect
107:805-812 (1999). [Online 1 September 1999]
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Because society has made human health and
safety an important consideration, consid-
erable resources have been and are being
expended in efforts to identify and classify
human carcinogens. Unfortunately, methods
currently used, such as the Ames test (1) and
in vivo animal testing, suffer from several
shortcomings. These include the need to
extrapolate from prokaryotes to humans
(Ames test) and the need to extrapolate from
rodents to humans, the high cost, and the
long period before results are known (in vivo
animal testing). With all current methods
there is also limited predictivity, both when
examining the agreement ofvarious methods
with eachother (2-6) andwhen applying lab-
oratory results toactual humanpopulations.
To aid in the development and valida-
tion of improved ways to predict the car-
cinogenicity of compounds, the National
Institute of Environmental Health Sciences
(NIEHS; Research Triangle Park, NC) initi-
ated the predictive toxicology evaluation
project (PTE). This project listed two sets of
chemicals undergoing in vivocarcinogenicity
testing; the first set of 44 chemicals was
listed in 1990 (PTE1) and the second set of
30 chemicals in 1994 (PTE2) (7,8).
Researchers were invited to submit predic-
tions regarding the ability ofthese chemicals
to induce carcinogenesis in rodents, and the
predictions and actual in vivo results were
to be compared when the animal results
became available. The results from PTE1
provided information regarding the features
of chemicals most predictive of their ability
to act as carcinogens, and the results from
PTE2 will add to this dataset once all ofthe
in vivo results are available for comparison
with the predictions.
We previouslydeveloped a novel method
for assessing the genotoxicity of substances
that is simple, rapid, and cost-effective. This
method is based on the biologic response of
mammalian cells in culture to agents that
damage their DNA (9). This assay is based
on the well-documented observation that the
cellular level of a tumor-suppressor protein
called p53 increases following DNA damage
(10-15), primarily because of an increase in
the stability of the protein and a resulting
decrease in its rate ofproteolysis (9,10). The
p53 then acts to prevent replication of
damaged DNA, either by causing the cell
to undergo a reversible growth arrest
(11,16,17) or by initiating a cell's apoptotic
pathway (18-21).
The assay itself is simple (9). Cultured
mammalian cells (NCTC 929) are treated
with various doses of the test agent, and at
specified time points following treatment, the
cells are harvested and lysed. The level ofp53
in the lysates is measured by p53 enzyme-
linked immunosorbent assay (ELISA) and/or
Western blot analysis, and compared to the
level in untreated cells.
Our previous work (9) indicated that
both Western blot and ELISA analyses yield-
ed similar results. Therefore, our current
work focused on the more quantitative
ELISA assay. We also found that the NCTC
929 cell line was a useful model system.
NCTC 929 cells were initially selected
because previously published results (10)
indicated that their levels ofp53 rise follow-
ing genotoxin treatment. We verified this,
and found in addition that p53 in these cells
can be immunoprecipitated by a monoclonal
antibody specific for wild-type p53. We also
found that the level ofp53 in these cells rises
significantly following treatment with indi-
rect genotoxins such as aflatoxin BI and 2-
acetylaminofluorene, indicating that they
possess significant amounts ofthe metabolic
activities necessary for biotransformation (9.
To determine the ability of this assay to
predict carcinogenicity in rodents and to
compare its performance with other proposed
alternatives, we subjected 25 ofthe 30 PTE2
substances to analysis by this method. Five
substances (citral, cobalt sulfate heptahydrate,
D&C Yellow No. 11, oxymetholone, and t-
butylhydroquinone) tested positive in this
assay and three substances (emodin, phe-
nolphthalein, and sodium xylenesulfonate)
tested as possibly positive. Comparisons
between the results obtained with this assay
and those obtained with the in vivo protocol,
the Salmonella assay, and the Syrian hamster
embryo (SHE) cells indicate that the p53-
induction assay is an excellent predictor ofthe
limited number of genotoxic carcinogens in
this set, and that its accuracy is roughlyequiv-
alent to or better than the Salmonella and
SHEassays forthecomplete setofchemicals.
Materials and Methods
Cell culture. These experiments were done
using the NCTC 929 cell line derived
from mouse fibroblasts and obtained from
the American Type Culture Collection
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(Rockville, MD). Cells were cultured in
modified Eagle media (Gibco/Life Sciences,
Gaithersburg, MD) supplemented with 10%
fetal calf serum (Gibco) (MEM 10). Cells
were plated at a density of 0.5-1.5 x 106
cells per 100 mm plate 1 day prior to treat-
ment. pAB 122 hybridoma cells, also
obtained from the American Type Culture
Collection, were propagated in Dulbecco's
modified Eagle medium supplemented with
10% fetal calf serum, and served as the
source for the primary anti-p53 antibody
used in the ELISA analysis.
Chemicals. Fourteen ofthe 25 substances
tested were obtained from the NIEHS. These
substances and their Chemical Abstract
Service (CAS) numbers are as follows: codeine
(76-57-3); D&CYellow No. 11 (8003-22-3);
diethanolamine (111-42-2); 1,2-dihydro-
2,2,4-trimethylquinoline (147-47-7); eth-
ylbenzene (100-41-4); ethylene glycol
monobutyl ether (111-76-2); furfuryl alcohol
(98-00-0); gallium arsenide (1303-00-0);
methyleugenol (93-15-2); oxymetholone
(434-07-1); phenolphthalein (77-09-8); pri-
maclone (125-33-7); pyridine (110-86-1);
and scopolamine hydrobromide trihydrate
(6533-68-2). Ten substances were obtained
from Sigma/Aldrich (St. Louis, MO):
1-chloro-2-propanol (127-00-4), citral
(5392-40-5), cobalt sulfate heptahydrate
(10026-24-1), emodin (518-82-1), isobu-
tyraldehyde (78-84-2), nitromethane (75-
52-5), sodium nitrate (7632-00-0), sodium
xylenesulfonate (1300-72-7), t-butylhydro-
quinone (1948-33-0), and tetrahydrofuran
(109-99-9). Cinnamaldehyde (104-55-2)
was obtained fromAcros (Pittsburgh, PA).
Unless noted otherwise, 10 mg/mL stock
solutions of the test substances were pre-
pared in either culture media (MEM 10) or
in dimethylsulfoxide (DMSO). We have
previously shown that DMSO alone at the
concentrations used does not induce p53 in
treated cells (9).
Cell treatment. Volumes of the stock
solution corresponding to the doses tested
were added to a series ofplates (approximate-
ly 1 x 106 cells per 100 mm plate in a vol-
ume of 10-mL MEM 10). Control plates
were treated with an amount ofvehicle alone
(media or DMSO) that corresponded to the
highest volume added to the experimental
plates. For each chemical, several doses
between 1 and 100 pg/mL of the test sub-
stance were evaluated; the exact doses used
are listed in the sections for the separate
chemicals. Treated and control cells were
incubated at 37°C and 5% CO2 until har-
vest. One series was harvested approximately
6 hr posttreatment, and a second series was
harvested approximately 17 hr posttreatment.
Each chemical was tested, at the several
dosages and at the two time points, between
two and four times. In some cases, specific
doses were repeated in additional trials.
To ensure that the p53 response ofthese
cells to both direct- and indirect-acting
genotoxic chemicals remained intact and rel-
atively constant during these experiments,
cultures of NCTC 929 cells from passages
currently in use were periodically treated
with known direct (N-methyl-N'-nitro-
nitrosoguanidine) and indirect (mitomycin
C) genotoxins (9) to verify that the cells
could adequately respond to both types of
chemicals. We found that the cellular
response to both direct- and indirect-acting
chemicals was stable throughout and beyond
the course ofthese experiments.
Celllysis andp53 ELISA. Cells were har-
vested, lysed, and analyzed for their protein
concentration by the BCA assay (Pierce,
Rockford, IL) and for their p53 levels by
ELISA, as described previously (9). Briefly,
cells were removed from the plate by
trypsinization, concentrated by centrifuga-
tion, and suspended in lysis buffer. After lysis,
lysates were stored at -80°C for no more than
1 week prior to analysis. The ELISA analysis
used pAB 122 as the primary or capture anti-
body, biotinylated anti-p53 (Boehringer
Mannheim, Annapolis, IN) as the detection
antibody, and GST-p53 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) as a
standard. Each point was measured in tripli-
cate, and the results were normalized to the
amount ofprotein present in each sample.
Analysis. Data were analyzed using one-
wayanalysis ofvariancesoftware (SuperAnova,
Abacus Concepts, Berkeley, CA). The Scheffe
S-test was used posthoc to identify significant
differences between p53 levels in treated and
untreated cells. Test results were interpreted
as positive ifone or more doses yielded a sig-
nificant increase (p < 0.001) in the level of
p53 in treated versus untreated cells, in two
or more separate experiments, at one or both
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of the times tested (6 and 17 hr), and with
no more than one of three or four experi-
ments failing to show such an increase.
Results were interpreted as possibly positive
using the same criteria, except that the sig-
nificance ofthe increasewas less (p < 0.05).
Data regarding the Salmonella and in
vivo results (where available) were obtained
from the PTE2 website (8).
Results
Cobalt sulfate heptahydrate and D&C
Yellow No. 11 inducep53 strongly by 6hr.
Two substances, cobalt sulfate heptahydrate
and D&C Yellow No. 11, caused increases in
cellular p53 by 6 hr. The increases for cobalt
sulfate heptahydrate were significant at both
50 and 100 pg/mL, and those for D&C
Yellow No. 11 were significant at 5, 10, and
25 pg/mL. On the basis ofthese results, they
are classified as positive. Figure 1 depicts rep-
resentative experiments for cells treated with
each of these substances and harvested at 6
hr. For these two substances, the increase in
the cellular level of p53 in cells treated with
the statistically significant doses is robust-
greater than a 4-fold increase over that seen
in untreated cells.
Citral cobaltsulfateheptahydrate, D&C
YellowNo. 11, oxymetholone, andt-butylhy-
droquinone inducep53 strongly by 17hr. In
addition to the two substances that induced
p53 by 6 hr, three additional substances
caused significant increases in the cellular
level ofp53 by 17 hr (citral, oxymetholone,
and t-butylhydroquinone). The increase for
citral was significant at doses of 10, 15, 20,
25, and 30 pg/mL; some cytotoxicity was
noted at 25 and 30 pg/mL and increased
cytotoxicity at 50 pg/mL. The increases for
cobalt sulfate heptahydrate were significant at
doses of 20 and 50 pg/mL; significant cyto-
toxicity was noted in cells treated with 100
ig/mL for 17 hr. Cells treated with 25
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Figure 1. Chemicals that strongly increased cellular p53 levels by 6 hr. (A) Cobalt sulfate heptahydrate. (B)
D&C Yellow No. 11. Cultured mammalian (NCTC 929) cells were treated with the indicated doses of the
test substances, then harvested and lysed at 6 hr posttreatment. The level of p53 present in the lysates
was quantitated by enzyme-linked immunosorbent assay, as described in "Materials and Methods." Error
bars represent standard error.
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ig/mL D&C Yellow No. 11 for 17 hr
showed a significant increase in their cellular
p53 level; cells treatedwith a higher level dis-
played cytotoxicity. Oxymetholone caused
significant increases in the p53 level at doses
of10 and 25 pg/mL, with increasingcytotox-
icity noted at doses of 25 and 50 pg/mL.
Finally, t-butylhydroquinone significantly
increased cellular p53 levels at doses of 1, 5,
and 10 pg/mL, with significant cytotoxicity
noted at higher doses. On the basis ofthese
results, these five substances are classified as
positive. Figure 2 depicts representative
experiments for cells treated with each of
these substances and harvested at 17 hr. For
each of the substances that tested positive,
the increase in the cellular level of p53 in
cells treated with the statistically significant
doses is robust-greater than a 4-fold
increase over thatseen in untreated cells.
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andsodium 1,2-dihydro-2,2,4-trimethylquinoline, ethyl-
trongly by 17 benzene, ethylene glycol monobutyl ether,
53 levels at a furfuryl alcohol, gallium arsenide, isobu-
lein at a dose tyraldehyde, methyleugenol, nitromethane,
;odium xyle- primaclone, pyridine, scopolamine hydrobro-
ig/mL. In the mide trihydrate, sodium nitrite, and tetrahy-
e significance drofuran) were unable to reproducibly and
noted forthe significantly increase cellular p53 levels at the
ussed; hence, times and doses tested. Based on these
sitives. Figure results, theyareclassified as negative.
ients for cells Substances classifiedon the basis oftheir
nces and har- ability to increase cellularp53. Table 1 lists
he increase in the substances that testedpositive (p < 0.001)
K 2- to 3-fold or possibly positive (p < 0.05) in this assay,
as compared along with the time(s) and dose(s) at which
mces. positive results wereachieved. Fivesubstances
not increase (citral, cobalt sulfate heptahydrate, D&C
aining seven- Yellow No. 11, oxymetholone, and t-butyl-
2-propanol, hydroquinone) gave clearly positive signals.
thanolamine, Cobalt sulfate heptahydrate and D&C
Yellow No. 11 were positive at both the early
and late time points, whereas the remaining
'g =|ts three were positive only at the later time
point. Three substances (emodin, phenolph-
thalein and sodium xylensulfonate) were
possibly positive in our assay. That is, they
demonstrated the ability to reproducibly
-| i1 X k induce p53 at at least one tested dose,
although the increase was lesssignificant than
seen with theprevious five substances.
Summary. Table 2 shows the summary
data for the substances that we tested as well
_ as previously reported results from the
20 50 Salmonella and SHE assays (22). It also lists a
summaryofthe in vivotest resultswhereavail-
able. In this table, the either- or single-species
in vivo test results are listed as positive ifthere
is some or dear evidence ofcarcinogenicity in
any of the four treatment groups; the
transspecies results are listed as positive only if
there was some or dear evidence ofcarcino-
genicity in eachofthe two testedspecies.
Specific notes regarding the individual
substances tested follow. Classifications (pos-
itive, possibly positive, and negative) refer to
the results ofthisstudy.
1-Chloro-2-propanol. A 10-mg/mL
stock of 1-chloro-2-propanol was prepared in
10 25 DMSO, and cells were treated with doses of
1, 5, 10, 25, and 50 pglmL. Cells treated
with 1-chloro-2-propanol did not display eat strongly cytotoxicity at any of the times or doses
3te heptahy- tested, and 1-chloro-2-propanol did not
No. 11. (D) induce p53 at any ofthe doses or times test-
ydroquinone ed. 1-Chloro-2-propanol is therefore classi-
FC 929) cells fied as negative by this method; this contrasts
ateddoses of with positive results in the Salmonella test
iarvested and and the SHE assay. The in vivo test results
t.The level of
wasquantitat- were also negative.
in 'Materials Cinnamaldehyde. A 10-mg/mL stock of
rs represent cinnamaldehyde was prepared in DMSO, and
cells were treated with doses of 1, 10, 20, and
50[ig/mL. Cells treated with cinnamaldehyde
displayed cytotoxicity at the highest dose
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tested (50 gg/mL) at both 6 and 17 hr.
Cinnamaldehyde did not induce p53 atanyof
the doses or times tested, and is therefore
classified as negative. The Salmonella results
wereweaklypositive.
Citral. A 10-mg/mL stock of citral was
prepared in DMSO, and cells were treated
with doses of 1, 5, 10, 15, 20, 25, 30, and 50
pg/mL. Cells treated with citral displayed
increasing cytotoxicity at the highest doses
tested (25, 30, and 50 mg/mL) by 6 and 17
hr. Citral induced p53 by 17 hr, and is there-
fore classified as positive. This contrasts with
the results from the Salmonella test, which
was negative.
Cobalt sulfate heptahydrate. A 10-
mg/mL stock ofcobalt sulfate heptahydrate
was prepared in H20, and cells were treated
with doses of 1, 10, 20, 50, and 100 pig/mL.
Cells treated with cobalt sulfate heptahydrate
displayed cytotoxicity when treated with the
substance at 100 pg/mL for 17 hr. Cobalt sul-
fate heptahydrate strongly induced p53 at
both the 6 and 17 hr time points, and is
therefore dassified as positive. The Salmonella
test gave a weakly positive response, and the
SHE assaywas also positive. Animal tests have
shown some evidence for carcinogenicity in
male rats and dear evidence forcarcinogenici-
ty in female rats, malemice, andfemale mice.
Codeine. A 10-mg/mL stock of codeine
was prepared in DMSO, and cells were treat-
ed with doses of 1, 5, 10, 25, and 50 Pg/mL.
Cells treated with codeine did not display
cytotoxicity at any ofthe times or doses test-
ed, and codeine did not induce p53 at any of
the doses or times tested. Codeine is there-
fore classified as negative. This is in agree-
mentwith the negative test results seen in the
Salmonelaand SHE assays, and alackofevi-
dence for carcinogenicity seen in the animal
tests.
D&C Yellow No. 11. A 5-mg/mL stock
of D&C Yellow No. 11 was prepared in
DMSO, and cells were treated with doses of
1, 5, 10, 25, and 50pg/mL. Cells treatedwith
D&CYellowNo. 11 displayed some cytotox-
icity at 50 pg/mL by 17 hr. The actual doses
received by the cells were less than those
administered, as some precipitation of the
substance was observed after its addition to
the media. Cells took up the dye; cell pellets
were yellow. This color partitioned with the
membrane fraction during centrifugation of
the lysate. D&C Yellow No. 11 strongly
induced p53 at both 6 and 17 hr, and is
therefore classified as positive. The Salmonella
test gave awealdy positive result, the SHE test
results were positive, and in animal studies,
male and female rats showed some evidence
ofcarcinogenicity.
Diethanolamine. A 10-mg/mL stock of
diethanolamine was prepared in DMSO,
and cells were treated with doses of 1, 5, 10,
25, and 50 pg/mL. Cells treated with
diethanolamine did not display cytotoxicity
at any of the times or doses tested, and
diethanolamine did not induce p53 at any of
the doses or times tested. Diethanolamine is
therefore classified as negative. This is in
agreement with a negative result in the
Salmonella assay, and contrasts with a posi-
tive result from the SHE test. During animal
testing, no evidence for carcinogenicity was
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seen in male or female rats, whereas clear evi-
dencewas observed in male and female mice.
1,2-Dihydro-2,2,4-trimethylquinoline
(DTQ). A 10-mg/mL stockofDTQwas pre-
pared in DMSO, and cells were treated with
doses of 1, 5, 10, 25, and 50 jig/mL. Cells
treated with DTQ did not displaycytotoxici-
ty at any of the times or doses tested, and
DTQ did not induce p53 at any ofthe doses
or times tested. DTQ is therefore dassified as
3.0 A...........Q
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Figure 3. Chemicals that increased
cellular p53 levels to a lesser extent.
(A) Emodin. (B) Phenolphthalein. (C)
Sodium xylenesulfonate. Cultured
mammalian (NCTC 929) cells were
treated with the indicated doses of
the test substances, then harvested
and lysed at 17 hr. The level of p53
present in the lysates was quantitat-
ed by enzyme-linked immunosorbent
assay, as described in 'Materials
and Methods." Error bars represent
standard error.
Dose(jg/mL)
Table 1. Positive and possibly positive substances.
Time(s) of Dose(s) of p-Value
PTE2 no. Chemical observed induction observed induction (exp 1, exp 2)
Positive
5 Citral 17 hr 10 pg/mL 0.0019, 0.0001
15 pg/mL 0.0001, 0.0001
20 pg/mL 0.0001, 0.0001
25 pg/mL 0.0001, 0.0001
30 pg/mL 0.0001, 0.0001
6 Cobalt sulfate 6 hr 50 pg/mL 0.0001, 0.0001
heptahydrate 100 pg/mL 0.0001, 0.0001
17 hr 20 pg/mL 0.0001, 0.0001
50 pg/mL 0.0001, 0.0001
8 D&C Yellow No. 11 6 hr 5 pg/mL 0.0016, 0.0001
10 pg/mL 0.0001, 0.0001
25pg/mL 0.0015, 0.0001
17 hr 25 pg/mL 0.0001, 0.0485
21 Oxymetholone 17 hr 10 pg/mL 0.0001, 0.0001
25 pg/mL 0.0001, 0.0001
28 t-Butylhydroquinone 17 hr 1 pg/mL 0.0001, 0.0001
5 pg/mL 0.0001, 0.0001
10 pg/mL 0.0001, 0.0001
Possibly positive
11 Emodin 17 hr 20 pg/mL 0.0110, 0.0435
22 Phenolphthalein 17 hr 10 pg/mL 0.0387, 0.0039
27 Sodiumxylensulfonate 17 hr 1 pg/mL 0.0035,0.0001
5 pg/mL 0.0001, 0.0025
Abbreviations: exp, experiment; PTE2, predictive toxicology evaluation 2.
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negative. This is in agreement with a negative
result from the Salmonella assay, and contrasts
with a positive result from the SHE test. The
animal results list some evidence for carcino-
genicity in male rats and no evidence in
female rats, male mice, and female mice.
Emodin. A 10-mg/mL stock of emodin
was prepared in DMSO, and cellswere treated
with doses of0.5, 1, 10, 20, and 50 pg/mL.
Cells treated with emodin displayed some
cytotoxicity when treated with the substance
at 50 ,ug/mL for 17 hr. Emodin weakly
induced p53 by 17 hr, and is therefore dassi-
fied as possibly positive. The Salmonelal and
SHE tests gave positive responses.
Ethylbenzene. A 10-mg/mL stock of
ethylbenzene was prepared in DMSO, and
cells were treated with doses of1, 10, 20, and
50 gg/mL. Cells treated with ethylbenzene
did not display significant cytotoxicity at any
ofthe times ordoses tested, andethylbenzene
did not induce p53 at any of the doses or
times tested. Ethylbenzene is therefore dassi-
fied as negative. This is in agreement with a
negative result from the Salmonella assay and
contrasts with a positive result from the SHE
test. The animal results list dear evidence for
carcinogenicity in male rats, and some
evidence in female rats, male mice, and
female mice.
Ethylene glycol monobutyl ether
(EGMBE). A 10-mg/mL stock of EGMBE
was prepared in MEM 10, and cells were
treated with doses of 1, 5, 10, 25, and 50
pig/mL. Cells treated with EGMBE did not
display cytotoxicity at any of the times or
doses tested, and EGMBE did not induce
p53 at any of the doses or times tested.
EGMBE is therefore classified as negative.
This is in agreement with a negative result
from the Salmonella assay and contrasts with
a positive result from the SHE assay. The
animal results list some evidence in male and
female mice, no evidence in male rats, and
equivocal evidence in female rats.
Furfuryl alcohol. A 10-mglmL stock of
furfuryl alcohol was prepared in MEM 10,
and cells were treated with doses of 1, 5, 10,
25, and 50pg/mL. Cells treated with furfuryl
alcohol did not display cytotoxicity at any of
the times or doses tested, and furfuryl alcohol
did not induce p53 at any of the doses or
times tested. Furfuryl alcohol is therefore
classified as negative. This is in agreement
with negative results from the Salmonella and
the SHE assays. The animal results list equiv-
ocal evidence for carcinogenicity in female
rats, some evidence in male rats and mice,
and no evidence in female mice.
Gallium arsenide. A 1-mg/mL stock of
gallium arsenide was prepared in DMSO,
and cells were treated with doses of 1, 10,
20, and 50 pg/mL. The actual dose received
by the cells is lower than that listed, as some
Table2. Summary and comparisons.
PTE2 Salmonella p53 SHE In vivo
no. Name CAS no. results induction cell results resultsa
1 Anthraquinone 84-65-1 + NT
2 Chloroprene 126-99-8 - NT NT +/+
3 1-Chloro-2-propanol 127-00-4 + - + -/-
4 Cinnamaldehyde 104-55-2 +w - NT
5 Citral 5392-40-5 + NT
6 Cobalt sulfate heptahydrate 10026-24-1 +w + + +/+
7 Codeine 76-57-3 - - - -/-
8 D&C Yellow No. 11 8003-22-3 +w + + +/NT
9 Diethanolamine 111-42-2 - - + +/-
10 1,2-Dihydro-2,2,4-trimethylquinoline 147-47-7 - - + +/-
11 Emodin 518-82-1 + Possibly + +
12 Ethylbenzene 100-41-4 - - + +/+
13 Ethylene glycol monobutyl ether 111-76-2 - - + +/-
14 Furfuryl alcohol 98-00-0 - - - +/+
15 Gallium arsenide 1303-00-0 - - +
16 Isobutene 115-11-7 - NT NT +/-
17 Isobutyraldehyde 78-84-2 ? - - -/-
18 Methyleugenol 98-15-5 - - + +/+
19 Molybdenum trioxide 1313-27-5 - NT + +/-
20 Nitromethane 75-52-5 - - + +/+
21 Oxymetholone 434-07-1 - + + +/NT
22 Phenolphthalein 77-09-8 - Possibly + + +/+
23 Primaclone 125-33-7 + - - +/-
24 Pyridine 110-868-1 - - - +/+
25 Scopolamine hydrobromide trihydrate 6533-68-2 - + -/-
26 Sodium nitrite 7632-00-0 + - +
27 Sodium xylenesulfonate 1300-72-7 - Possibly + - -/-
28 t-Butylhydroquinone 1948-33-0 - + - -/-
29 Tetrahydrofuran 109-99-9 - - - +/+
30 Vanadium pentoxide 1314-62-1 - NT +
Abbreviations: +, positive; -, negative; CAS, Chemical Abstracts Registry; NT, not tested; PTE2, predictive toxicology
project 2; SHE, Syrian hamster embryo; w,weak.
"Eitherspecies/transspecies.
precipitation could be observed following
the addition of the substance to the media.
Cells treated with gallium arsenide displayed
some cytotoxicity at the highest doses tested
(20 and 50 pg/mL), and gallium arsenide
did not induce p53 at any of the doses or
times tested. Gallium arsenide is therefore
classified as negative. This is in agreement
with a negative result from the Salmonella
assay and contrasts with a positive result
from the SHE assay.
Isobutyraldehyde. A 10-mg/mL stock of
isobutyraldehyde was prepared in DMSO,
and cells were treated with doses of 1, 10, 20,
50, and 100 ,glmL. Cells treated with isobu-
tyraldehyde did notdisplaycytotoxicity at any
ofthe times or doses tested, and isobutyralde-
hyde did not induce p53 at any ofthe doses
or times tested. Isobutyraldehyde is therefore
classified as negative. The Salmonella results
were incondusive, the SHE results were nega-
tive, and no evidence for carcinogenicity was
observed in male or female rats or in male or
female mice.
Methyleugenol. A 10-mg/mL stock of
methyleugenol was prepared in DMSO,
and cells were treated with doses of 1, 5,
10, 25, and 50 pg/mL. Cells treated with
methyleugenol did not display cytotoxicity
at any of the times or doses tested, and
methyleugenol did not induce p53 at any of
the doses or times tested. Methyleugenol is
therefore classified as negative. This is in
agreement with a negative result from the
Salmonella assay and contrasts with a posi-
tive result from the SHE assay. In vivo test
results showed clear evidence for carcino-
genicity in male and female rats and male
and female mice.
Nitromethane. A 10-mg/mL stock of
nitromethane was prepared in DMSO, and
cells were treated with doses of 1, 10, 20, and
50 pg/mL. Cells treated with nitromethane
did not display cytotoxicity at any of the
times or doses tested, and nitromethane did
not induce p53 at any of the doses or times
tested. Nitromethane is therefore classified as
negative. This is in agreement with a negative
result from the Salmonellaassay, and contrasts
with a positive result from the SHE assay.
The animal results list no evidence for car-
cinogenicity in male rats and clear evidence in
female rats, male mice, and female mice.
Oxymetholone. A 10-mg/mL stock of
oxymetholone was prepared in DMSO,
and cells were treated with doses of 1, 5,
10, 25, and 50 pg/mL. Cells treated with
oxymetholone displayed cytotoxicity at 50
pg/mL by 6 hr and at 25 and 50 pg/mL by
17 hr. Oxymetholone strongly induced p53
by 17 hr, and is therefore classified as posi-
tive. This is in contrast to a negative result
from the Salmonella assay, but in agreement
with a positive result from the SHE assay.
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Animal results showed equivocal results in
male rats and clear evidence in female rats.
Mice were not tested.
Phenolphthalein. A 10-mglmL stock of
phenolphthalein was prepared in DMSO,
and cells were treatedwith doses of1, 10, 20,
40, and 50 pg/mL. Cells treated with phe-
nolphthalein did not display cytotoxicity at
any of the times or doses tested, and phe-
nolphthalein induced p53 weakly by 17 hr.
Phenolphthalein is therefore classified as pos-
siblypositive. This is in contrast to a negative
result from the Salmonella assay, and in
agreement with a positive result from the
SHE assay. The animal results list clear evi-
dence for carcinogenicity in male rats, male
mice, and female mice, and some evidence in
female rats.
Primaclone. A 10-mg/mL stock of
primaclone was prepared in DMSO, and
cells were treatedwith doses of1, 10, 20, and
50 pg/mL. Cells treated with primaclone did
not display cytotoxicity at any ofthe times or
doses tested, and primaclone did not induce
p53 at the doses and times tested. Primaclone
is therefore classified as negative. This is in
contrast with a positive result from the
Salmonella assay, but in agreement with a
negative result from the SHE assay. The ani-
mal results list equivocal evidence for car-
cinogenicity in male rats, no evidence in
female rats, and clear evidence in both male
and female mice.
Pyridine. A 10-mg/mL stock ofpyridine
was prepared in MEM 10, and cells were
treated with doses of 1, 5, 10, 25, and 50
pg/mL. Cells treated with pyridine did not
display cytotoxicity at any of the times or
doses tested, and pyridine did not induce
p53 at any of the doses or times tested.
Pyridine is therefore classified as negative.
This is in agreement with negative results
from the Salmonella and SHE assays. The
animal results list some evidence for carcino-
genicity in male rats, equivocal evidence in
female rats, and clear evidence for both male
andfemale mice.
Scopolamine hydrobromide trihydrate.
A 10-mg/mL stock of scopolamine hydro-
bromide trihydrate was prepared in DMSO,
and cells were treated with doses of 1, 5, 10,
25, and 50 jig/mL. Cells treated with scopo-
lamine hydrobromide trihydrate did not dis-
play cytotoxicity at any ofthe times or doses
tested, and scopolamine hydrobromide trihy-
drate did not induce p53 at any ofthe doses
or times tested. Scopolamine hydrobromide
trihydrate is therefore classified as negative.
This is in agreement with a negative result
from the Salmonella assay and contrasts with
a positive SHE result. The animal results list
no evidence forcarcinogenicity.
Sodium nitrate. A 10-mg/mL stock of
sodium nitrate was prepared in DMSO, and
cells were treated with doses of 1, 5, 10, 25,
and 50 jig/mL. Cells treated with sodium
nitrate did not display cytotoxicity at any of
the times or doses tested, and sodium nitrate
did not induce p53 at any of the times or
doses tested. Sodium nitrite is therefore clas-
sified as negative. The Salmonella and SHE
results were positive.
Sodium xylenesulfonate. A 10-mg/mL
stock of sodium xylenesulfonate was pre-
pared in DMSO, and cells were treated with
doses of 1, 5, 10, 25, and 50 pg/mL. Cells
treated with sodium xylenesulfonate did not
display cytotoxicity at any of the times or
doses tested, and sodium xylenesulfonate
induced p53 weakly by 17 hr. Sodium
xylenesulfonate is therefore classified as pos-
sibly positive. The Salmonella and SHE
results were negative, and no evidence ofcar-
cinogenicity was observed in male or female
rats or male or female mice.
t-Butylhydroquinone. A 10-mg/mL
stock of 5-butylhydroquinone was prepared
in DMSO, and cells were treated with doses
of 1, 5, 10, 25, and 50 pg/mL. Cells treated
with t-butylhydroquinone displayed cyto-
toxicity at 25 and 50 pg/mL by 17 hr, and
t-butylhydroquinone induced p53 by 17 hr.
t-Butylhydroquinone is therefore classified
as positive. This contrasts with negative
Salmonella and SHE assay results. No evi-
dence of carcinogenicity was observed in
male or female rats or male or female mice.
Tetrahydrofuiran. A 10-mg/mL stock of
tetrahydrofuran was prepared in DMSO, and
cells were treated with doses of 1, 5, 10, 20,
25, 50, and 100 ,ug/mL. Cells treated with
tetrahydrofiran did not display cytotoxicity
at any of the times or doses tested, and did
not induce p53 at any ofthe times or doses
tested. Tetrahydrofuran is therefore dassified
as negative. The Salmonella and SHE results
were negative. In animal studies, some evi-
dence for carcinogenicity was found in male
rats, no evidence in female rats and male
mice, and clearevidence in female mice.
Discussion
The purpose of this study was to determine
the ability of the newly developed p53-in-
duction assay to identify genotoxic sub-
stances and to predict carcinogenicity in
rodents. To this end, we subjected 25 ofthe
30 PTE2 substances to this test. Five sub-
stances strongly and reproducibly increased
cellular p53 levels and therefore were dassi-
fied as positive, three substances increased
cellular p53 levels, but to a less significant
extent and therefore were identified as possi-
bly positive, and seventeen substances did
not significantly increase cellular p53 levels
andwere therefore classified as negative.
Five of the PTE2 substances were not
tested. As currently configured, our assay
system is capable oftesting solid or liquid
substances that can be dissolved in culture
media to the required concentrations and
whichwill remain in solution for several hr at
37°C. Anthraquinone, molybdenum triox-
ide, and vanadium pentoxide were not tested
because ofthe limited solubility ofthese sub-
stances in water, culture media, and DMSO.
It may be possible in the future to identify
conditions that will allow us to deliver the
substances to the cells at the required concen-
trations. Isobutene is a gas at room tempera-
ture and was not tested; it may be possible in
the future to set up a delivery system that
would deliver a constant concentration ofthe
gas to cells in culture. Chloroprene was not
tested because it cannot beshipped.
The level of p53 detected in untreated
cells varied between experiments from a low
of undetectable (0) to a high of approxi-
mately 10 ng p53/mg total cellular protein.
Therefore, each experiment was analyzed
separately and the results ofreplicate experi-
ments compared with each other. We found
good agreement between experiments; for
most chemicals, all experiments demonstrat-
ed the same increase or lack ofincrease, and
with the same or a similar statistical signifi-
cance. For a few chemicals, one experiment
of three or four either failed to show the
same trend, or did show the same trend but
at alower level ofsignificance.
In this study we identified chemicals
that induced p53 but to a lesser extent and
to a lower level ofsignificance as possibly
positive. It may be that weakly positive
would be a more appropriate classification.
To distinguish between the two, it may be
helpful to perform additional trials ofthese
substances to confirm the reproducibility of
the observed increases.
The strength ofthis p53-induction assay
is expected to be in identifying genotoxic
compounds, ofwhich this PTE2 group con-
tains only a few. We therefore drew compar-
isons between results from the p53-induction
assayandthe in vivoresults forboth the entire
setoftestedcompounds andseparatelyforthe
genotoxic substances. Figure 4 summarizes
the comparisons between the Salmonel4, p53
induction, SHE, and in vivo test results.
Figure 4A compares the overall in vivo test
results with each ofthe three in vitro proto-
cols separately, and with a combination of
predictions from the three in vitro protocols.
In this analysis, chemicalswere dassified as in
vivopositives ifsome or dear evidence ofcar-
cinogenicity was obtained in either or both
species. Chemicals were classified as in vitro
positives ifthey tested either positive, possibly
positive, orweaklypositive. Analyses included
only those chemicals where both assays have
been done; or, in the case ofthe "any ofthe
three" analysis, all four assays have been done.
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This accounts for the differences in the totals
forthe induded analyses. Also, forthe "anyof
the three" analysis, a chemical is scored as in
vitro positive if any of the three tests
(Salmonella, p53 induction, or SHE) gave a
positive result. By these criteria, the
Salmonella test gave a concordance with the
in vivo test results of32%, the p53-induction
assay a concordance of40%, the "any ofthe
three" results a concordance of59%, and the
SHE assay a concordance of67%. Therefore,
by this analysis, the SHE test yielded the
highest concordance with the in vivo results,
followed by the composite, then the p53
induction, and finally the Salmonella assays.
These results also reflect the higher likelihood
ofthe SHE test to produce positive results for
this set ofchemicals, most ofwhich were also
positive in in vivotesting.
A comparison ofthe result from the p53-
induction assayand the in vivoresults foronly
thegenotoxiccompounds in thisgroup (those
that tested positive in the Salmonella assay)
shows that two substances were positive in
both (cobalt sulfate heptahydrate and D&C
YellowNo. 11), one substance waspositive in
vivo but negative in the p53-induction assay
(primaclone), and one substance was negative
in both assays (1-chloro-2-propanol). Ofthis
limited number ofgenotoxic compounds pre-
sent in the PTE2 list, thep53-induction assay
has aconcordance of75%.
Because the primary motivation in
performing these types of studies is the
protection of human health, transspecies
carcinogens may be ofgreater concern than
single-species carcinogens. Figure 4B compares
the in vivo test results for trans-species
carcinogens with each of the three in vitro
protocols separately, and with a combination
ofpredictions from the three in vitro proto-
cols. In this analysis, chemicals were classified
as in vivo positives only ifsome or clear evi-
dence of carcinogenicity was obtained in
both tested species; otherwise, the analysis
was as described for Figure 4A. By these cri-
teria, the "any of the three" results gave a
concordance of 35%, the Salmonella test a
concordance of 50%, the SHE assay a con-
cordance of 53%, and the p53-induction
assay a concordance of 56%. Therefore, by
this analysis, the p53-induction assayyielded
the highest concordance with the in vivo
results, followed by the SHE analysis, then
the Salmonella, and finally the composite
assays. Because fewer ofthe in vivoresults are
classified as positive by the transspecies crite-
ria, the concordance of the two assays less
likely to test positive for this set ofchemicals
(Salmonella and p53 induction) with the in
vivo test results was improved, and the con-
cordance ofthe two data sets more likely to
test positive for this set of chemicals (SHE
and "anyofthethree") decreased.
A comparison ofthe p53-induction assay
results and the transspecies in vivo results for
only the genotoxic compounds in this group
(those that tested positive in the Salmonella
assay) shows that one substance was positive
in both assays (cobalt sulfate heptahydrate)
and two substances were negative in both
assays (1-chloro-2-propanol and pri-
maclone). Of this limited number of geno-
toxic compounds present in the PTE2 list,
the p53-induction assay has a concordance
with the in vivoresults of100%.
Figure 4C compares results from the
three in vitro assays with each other. In this
analysis, only thosechemicals forwhich both
listed assays have been reported are induded.
The concordance of Salmonella and SHE
assays is 44%, that ofthe p53-induction and
SHE assays is 48%, and the p53-induction
and Salmonellaassays is 63%, indicating that
of the three, the p53 induction and the
Salmonella assays are the most like each
other, although still significantly different.
Based on the biology underlying the
Salmonella SHE, and p53-induction assays, it
seems clear that the p53-induction assay sens-
es afundamentally different type ofbiological
information than do the other methods. The
Ames test (1) is perhaps the most widely used
test for genotoxicity; it is based on the ability
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ofmutagens to alter the phenotype ofspecific
strains of Salmonella by inducing heritable
changes in its genetic material. The SHE test
likewise relies on heritable changes in the
morphology oftreated cells (22). In contrast,
the p53-induction assay takes advantage ofa
normal cellular response to DNA damage;
namely, the increase ofthe tumor-suppressor
protein p53. It is therefore not dependent on
a permanent change in DNA; rather, it works
by eavesdropping on the events that normally
follow DNAdamage.
An advantage of this assay, therefore, is
that it may be capable ofdetecting transitory
DNA damage that is repaired too quickly to
be detected in tests which require heritable
changes in the DNA. Diethylstilbestrol,
which produces DNA lesions with a short
biologic half-life, induced p53 [(9) and refer-
ences therein] while givinganegative orweak
response in the Salmonellaassay. This feature
is one possible explanation for substances
(such as sodium xylenesulfate or t-butylhy-
droquinone) testing positive or possibly posi-
tive in this assay while testing negative in the
in vivo tests; the substance may have caused
DNA damage that was quickly repaired
before DNAreplication.
Another possible explanation for chemi-
cals testing positive in this assay and negative
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Figure 4. Comparisons of assay results. Abbreviations: +, positive; -, negative; SHE, Syrian hamster
embryo. (A) In vitro results as compared to in vivo results (single- and transspecies carcinogens com-
bined). The results of the three in vitro assays (Salmonella, p53 induction, and SHE) were compared
againstthe in vivo results. Chemicals were classified as in vivopositives if some or clear evidence of car-
cinogenicity was obtained in either or both species. Forthe lastpanel,only Salmonellapositive chemicals
were included in the analysis. (B) In vitro results compared against in vivo results (transspecies carcino-
gens only). The results ofthe three in vitro assays were compared againstthe in vivo results. In this case,
chemicals were classified as in vivo positives only if some or clear evidence of carcinogenicity was
obtained in both tested species. For the last panel, only Salmonella positive chemicals were included in
the analysis. (C) Results from the three in vitro assays as compared to each other. For the "any of the
three" analyses in (A) and (B), a chemical is scored as in vitro positive if any ofthe three tests yielded a
positive result. Also, two chemicals (D&C Yellow No. 11 and oxymetholone) were tested only in one
species and are therefore included in the analysis in (A) but not in (B).
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in the in vivo protocol is that they could
cause increases in cellular p53 levels by a
mechanism independent of DNA damage
(23). For example, a substance that could
block proteosome function would be expect-
ed to increase cellular p53 (24,25). We have
found, however, that the ability of sub-
stances to increase p53 and to cause cellular
cytotoxicity is not correlated; indeed, most
substances do not induce p53 even when
clearly inducing stress and cytotoxicity [(9)
and this study]. Hence, it seems unlikely
that p53 induction is a general nonspecific
response to chemical or cytotoxic stress.
The p53-induction assay used in this
study utilized NCTC 929 cells, which are a
mouse fibroblast cell line. Although we have
shown that these cells can respond to indirect
genotoxins such as aflatoxin B1 by increasing
their level of p53, demonstrating the pres-
ence of activating metabolic enzymes, it is
possible that differences in the array ofmeta-
bolic activities in these cells as opposed to
liver extract could create a different combina-
tion of metabolites. This altered range of
activities could then either increase or
decrease DNA damage. This could account
for differences in the results noted with the
p53-induction assay and those noted for
other assays. It may be interesting to test a
subset of these substances for their ability to
induce p53 in a different cell line, perhaps
one derived from liver.
We have previously shown that the
increase in p53 is transient with respect to
time and is maximal at certain substance-
specific doses, and that a higher dose does
not necessarily lead to a higher level ofcellu-
lar p53. In this study, only a limited number
oftimes and doses could be tested. Based on
our previous work (9), direct-acting geno-
toxic chemicals induced p53 at early times
(2-8 hr), whereas indirect-acting genotoxic
chemicals induced p53 at later times (12-24
hr). Hence, we tested each ofthese 25 PTE2
chemicals at both early (6 hr) and late (17
hr) time points in an attempt to detect both
direct and indirect genotoxins. We found
that one chemical exerted significant effects
at more doses at the early time point than at
the latter (D&C Yellow No. 11), and that
others showed an effect at only the latter
time point (citral, oxymetholone, t-butylhy-
droquinone; compare Figure 2 and Figure
1). It is possible, however, that a substance
capable ofweakly inducing p53 could exert
its maximal effect at a time other than those
tested, and that any induction seen at the
tested times was not statistically significant.
Previously tested genotoxins yielded
maximal induction at doses between 1 and
100 pg/mL; therefore, for each of the 25
substances analyzed, we tested several doses
between 0.5 and 100 gg/mL. We found
that most of the chemicals that tested posi-
tive did so only at one or a few ofthe tested
doses, suggesting that the dose range at
which an effect can be observed may be
rather narrow. For a number of the sub-
stances, the higher doses (25, 50, and 100
j.g/mL) induced extensive cytotoxicity,
compromising the validity of the p53 assay
at those dosages. It is possible that a sub-
stance testing negative in our assay would
have tested positive at some other untested
dose. Our results were analyzed with the
Scheffe S-test, which is a relatively conserva-
tive post hoc test for differences.
The expected strength ofthis p53-induc-
tion assay is in the identification ofgenotox-
ic compounds. There were few ofthese com-
pounds in this PTE2 group, and with these
few compounds, the p53-induction assay did
an excellent job of identifying them. The
most likely explanation for the inability of
this assay to identify many of the carcino-
genic compounds in this group is that they
are epigenetic substances that cause cancer
by nongenotoxic mechanisms. Additionally,
factors such as absorption, distribution,
metabolism, and excretion, which operate in
whole animals but do not operate in in vitro
test systems, could play a role.
It has been suggested by Ashby and
Tennant (26) that carcinogenicity may result
from
a specific interaction between the chemical and
the tissue rather than it being an intrinsic and
unique property ofthe chemical;
therefore, it may well be that no one chemi-
cal feature or assaywill provide the predictiv-
ity desired. It may therefore be helpful to
add this new set ofinformation to that con-
sidered when evaluating the carcinogenic
potential of substances. For example, the
results of the p53-induction assay could be
considered as an input in the induction of
rules for predicting chemical carcinogenicity
in rodents (27).
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